Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 2007Cancer ResearchOpen Access

Curcumin Potentiates Antitumor Activity of Gemcitabine in an Orthotopic Model of Pancreatic Cancer through Suppression of Proliferation, Angiogenesis, and Inhibition of Nuclear Factor-κB–Regulated Gene Products

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAjaikumar B. KunnumakkaraIndian Institute of Technology GuwahatiSGSushovan GuhaUniversity of DelhiSKSunil KrishnanSmith Family

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kunnumakkara et al. (2007) studied this question.

synapsesocial.com/papers/69dea7477702a00918b0c47bhttps://doi.org/10.1158/0008-5472.can-06-4257
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1<i>De Novo</i> expression of intercellular adhesion molecule 1(ICAM‐1, CD54) in pancreas cancer1993 · 47 citations
  2. 2Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.1997 · 5,942 citations